NO174043C - Analogifremgangsmåte for fremstilling av terapeutisk aktive mettede fettsyreamider - Google Patents
Analogifremgangsmåte for fremstilling av terapeutisk aktive mettede fettsyreamiderInfo
- Publication number
- NO174043C NO174043C NO880774A NO880774A NO174043C NO 174043 C NO174043 C NO 174043C NO 880774 A NO880774 A NO 880774A NO 880774 A NO880774 A NO 880774A NO 174043 C NO174043 C NO 174043C
- Authority
- NO
- Norway
- Prior art keywords
- saturated fatty
- preparation
- fatty acid
- acid amides
- therapeutically active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C233/07—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C233/09—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an acyclic unsaturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/017,960 US4716175A (en) | 1987-02-24 | 1987-02-24 | Saturated fatty acid amides as inhibitors of acyl-CoA:cholesterol acyltransferase |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO880774D0 NO880774D0 (no) | 1988-02-23 |
| NO880774L NO880774L (no) | 1988-08-25 |
| NO174043B NO174043B (no) | 1993-11-29 |
| NO174043C true NO174043C (no) | 1994-03-09 |
Family
ID=21785503
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO880774A NO174043C (no) | 1987-02-24 | 1988-02-23 | Analogifremgangsmåte for fremstilling av terapeutisk aktive mettede fettsyreamider |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4716175A (fr) |
| EP (1) | EP0283742B1 (fr) |
| JP (1) | JPH07121895B2 (fr) |
| KR (1) | KR880009933A (fr) |
| AT (1) | ATE89814T1 (fr) |
| CA (1) | CA1336913C (fr) |
| DE (1) | DE3881249T2 (fr) |
| DK (1) | DK165406C (fr) |
| ES (1) | ES2056843T3 (fr) |
| FI (1) | FI89593C (fr) |
| HK (1) | HK148195A (fr) |
| IE (1) | IE59998B1 (fr) |
| MX (1) | MX9203139A (fr) |
| NO (1) | NO174043C (fr) |
| NZ (1) | NZ223410A (fr) |
| PT (1) | PT86811B (fr) |
| ZA (1) | ZA88604B (fr) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5290814A (en) * | 1988-11-21 | 1994-03-01 | Burroughs Wellcome Co. | Anti-atherosclerotic diaryl compounds |
| GB8827152D0 (en) * | 1988-11-21 | 1988-12-29 | Wellcome Found | Anti-atherosclerotic diaryl compounds |
| US5153226A (en) * | 1989-08-31 | 1992-10-06 | Warner-Lambert Company | Acat inhibitors for treating hypocholesterolemia |
| MX22406A (es) * | 1989-09-15 | 1994-01-31 | Pfizer | Nuevos derivados de n-aril y n-heteroarilamidas y urea como inhibidores de acil coenzima a: acil transferasa del colesterol (acat). |
| AU6659090A (en) * | 1989-11-16 | 1991-06-13 | Warner-Lambert Company | Acat inhibitors |
| WO1991015464A1 (fr) * | 1990-04-11 | 1991-10-17 | Warner-Lambert Company | Esters d'amides inhibiteurs de acat |
| US5149709A (en) * | 1990-07-03 | 1992-09-22 | Schering Corporation | Inhibitors of acyl-coenzyme A: cholesterol acyl transferase |
| ATE161837T1 (de) * | 1990-07-25 | 1998-01-15 | Teijin Ltd | Benzopyran derivat, seine darstellung und pharmazeutische zusammensetzung, welche dieses enthält |
| US5668136A (en) * | 1990-09-25 | 1997-09-16 | Eisai Co., Ltd. | Trisubstituted benzene derivatives, composition and methods of treatment |
| ES2088574T3 (es) * | 1990-11-26 | 1996-08-16 | Taisho Pharmaceutical Co Ltd | Derivado de anilida. |
| FR2673625B1 (fr) * | 1991-03-08 | 1993-05-07 | Adir | Nouveaux derives d'acylaminophenol, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| US5420164A (en) * | 1991-04-04 | 1995-05-30 | Yoshitomi Pharmaceutical Industries, Ltd. | Cycloalkylurea compounds |
| AU660346B2 (en) * | 1991-12-25 | 1995-06-22 | Taisho Pharmaceutical Co., Ltd. | Anilide derivative |
| BR9306421A (pt) * | 1992-05-28 | 1998-09-15 | Pfizer | Novos derivados n-aril e n-heteroariluréia como inbidores da acilcoenzima a:colesterol aciltransferase (acat) |
| EP0609457B1 (fr) * | 1992-07-20 | 1997-10-29 | Eisai Co., Ltd. | Derive du benzene |
| US5321031A (en) * | 1992-09-23 | 1994-06-14 | Schering Corporation | 1,2-disubstituted ethyl amides as inhibitors of ACAT |
| CA2107196A1 (fr) * | 1992-09-29 | 1994-03-30 | Mitsubishi Chemical Corporation | Derives de carboxamide |
| US5565472A (en) * | 1992-12-21 | 1996-10-15 | Pfizer Inc. | 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents |
| AU672699B2 (en) * | 1993-06-30 | 1996-10-10 | Sankyo Company Limited | Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses |
| NZ264063A (en) * | 1993-08-13 | 1995-11-27 | Nihon Nohyaku Co Ltd | N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions |
| US5596001A (en) * | 1993-10-25 | 1997-01-21 | Pfizer Inc. | 4-aryl-3-(heteroarylureido)quinoline derivatves |
| IT1265209B1 (it) * | 1993-11-22 | 1996-10-31 | Pierrel Spa | Difenilimidazoli utili nel trattamento di dislipidemia, arteriosclerosi e malattie coronariche procedimento per la loro |
| US6133326A (en) * | 1994-08-31 | 2000-10-17 | Pfizer Inc | Compositions and methods for decreasing sebum production |
| KR960031425A (ko) * | 1995-02-08 | 1996-09-17 | 시미주 마사미 | 다중불포화된 지방산 잔기를 갖는 아닐린 유도체 및 그의 용도 |
| AU781563B2 (en) | 2000-02-02 | 2005-06-02 | Warner-Lambert Company | Dual inhibitors of cholesterol ester and wax ester synthesis for sebaceous gland disorders |
| AU4368001A (en) * | 2000-03-16 | 2001-09-24 | Neurogen Corporation | 5-substituted arylpyrimidines |
| US20040072903A1 (en) * | 2001-05-08 | 2004-04-15 | Auerbach Bruce Jeffrey | Carboxyalkylether-acat inhibitors combinations |
| EP1281399A3 (fr) * | 2001-08-01 | 2004-02-11 | Warner-Lambert Company | Inhibiteurs doubles de la synthèse des des esters de cires et des esters du cholestérol pour inhiber la production de sébum |
| CA2558766A1 (fr) | 2004-03-05 | 2005-09-22 | The Trustees Of The University Of Pennsylvania | L'utilisation d'inhibiteurs mtp pour le traitement a faibles effets secondaires contre des affections liees a l'hyperlipidemie et l'hypercholesterolemie |
| CL2007002958A1 (es) * | 2006-10-12 | 2008-05-09 | Epix Delaware Inc | Compuestos derivados de heteroaril-carboxamida, antagonistas del receptor de quimioquina; composicion farmaceutica; y uso para el tratamiento o prevencion de enfermedades tales como rechazo de transplante de organos, artritis reumatoidea, lupus, entr |
| CN101925383A (zh) | 2007-12-11 | 2010-12-22 | 赛特帕斯凡德株式会社 | 甲酰胺化合物及其作为趋化因子受体激动剂的应用 |
| WO2010039801A2 (fr) | 2008-10-02 | 2010-04-08 | The J. David Gladstone Institutes | Méthodes de traitement d’une infection par le virus de l’hépatite c |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL120013C (fr) * | 1958-04-14 | |||
| BE620639A (fr) * | 1961-07-25 | |||
| SE353319B (fr) * | 1964-08-15 | 1973-01-29 | Sumitomo Chemical Co | |
| DE1618959C3 (de) * | 1967-10-04 | 1978-12-14 | Sumitomo Chemical Co., Ltd., Osaka (Japan) | Fettsäureamide und Verfahren zu ihrer Herstellung |
| DE2830351A1 (de) * | 1978-07-11 | 1980-01-24 | Consortium Elektrochem Ind | Acylanilide |
| GR69291B (fr) * | 1979-06-25 | 1982-05-13 | May & Baker Ltd | |
| GB2080808B (en) * | 1980-01-25 | 1984-01-04 | Reanal Finomvegyszergyar | Process for the preparation of n-aryl-n-(mono- or disubstituted)-urea derivatives |
| NZ216253A (en) * | 1985-05-27 | 1989-07-27 | Mitsui Toatsu Chemicals | N-(3-chloro-4-isopropylphenyl)-carboxamide derivatives and herbicidal compositions |
| MA20552A1 (fr) * | 1985-10-11 | 1986-07-01 | Pan Medica Sa | Alkylacarboxamides de pyridylalkylamines,leurs preparations et leurs utilisations |
-
1987
- 1987-02-24 US US07/017,960 patent/US4716175A/en not_active Expired - Lifetime
-
1988
- 1988-01-26 IE IE20488A patent/IE59998B1/en not_active IP Right Cessation
- 1988-01-27 CA CA000557467A patent/CA1336913C/fr not_active Expired - Fee Related
- 1988-01-28 ZA ZA88604A patent/ZA88604B/xx unknown
- 1988-02-04 NZ NZ223410A patent/NZ223410A/xx unknown
- 1988-02-19 FI FI880796A patent/FI89593C/fi not_active IP Right Cessation
- 1988-02-23 DE DE8888102644T patent/DE3881249T2/de not_active Expired - Fee Related
- 1988-02-23 ES ES88102644T patent/ES2056843T3/es not_active Expired - Lifetime
- 1988-02-23 AT AT88102644T patent/ATE89814T1/de not_active IP Right Cessation
- 1988-02-23 NO NO880774A patent/NO174043C/no unknown
- 1988-02-23 EP EP88102644A patent/EP0283742B1/fr not_active Expired - Lifetime
- 1988-02-23 DK DK094188A patent/DK165406C/da not_active IP Right Cessation
- 1988-02-23 JP JP63038777A patent/JPH07121895B2/ja not_active Expired - Lifetime
- 1988-02-23 PT PT86811A patent/PT86811B/pt not_active IP Right Cessation
- 1988-02-24 KR KR1019880001910A patent/KR880009933A/ko not_active IP Right Cessation
-
1992
- 1992-06-23 MX MX9203139A patent/MX9203139A/es unknown
-
1995
- 1995-09-14 HK HK148195A patent/HK148195A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA88604B (en) | 1989-09-27 |
| AU610558B2 (en) | 1991-05-23 |
| AU1135488A (en) | 1988-08-25 |
| FI89593B (fi) | 1993-07-15 |
| ATE89814T1 (de) | 1993-06-15 |
| DK94188A (da) | 1988-08-25 |
| PT86811B (pt) | 1992-05-29 |
| FI89593C (fi) | 1993-10-25 |
| NO174043B (no) | 1993-11-29 |
| CA1336913C (fr) | 1995-09-05 |
| NZ223410A (en) | 1989-11-28 |
| US4716175A (en) | 1987-12-29 |
| JPH07121895B2 (ja) | 1995-12-25 |
| IE880204L (en) | 1988-08-24 |
| JPS63253060A (ja) | 1988-10-20 |
| DK165406C (da) | 1993-04-13 |
| EP0283742B1 (fr) | 1993-05-26 |
| DE3881249D1 (en) | 1993-07-01 |
| FI880796A (fi) | 1988-08-25 |
| EP0283742A3 (en) | 1989-07-26 |
| NO880774D0 (no) | 1988-02-23 |
| HK148195A (en) | 1995-09-22 |
| DK165406B (da) | 1992-11-23 |
| IE59998B1 (en) | 1994-05-18 |
| KR880009933A (ko) | 1988-10-05 |
| EP0283742A2 (fr) | 1988-09-28 |
| US4716175B1 (fr) | 1993-06-22 |
| PT86811A (pt) | 1988-03-01 |
| FI880796A0 (fi) | 1988-02-19 |
| DK94188D0 (da) | 1988-02-23 |
| DE3881249T2 (de) | 1993-09-16 |
| ES2056843T3 (es) | 1994-10-16 |
| NO880774L (no) | 1988-08-25 |
| MX9203139A (es) | 1992-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO174043C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive mettede fettsyreamider | |
| NO180718C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive mercaptoacetylamidderivater | |
| NO180719C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive A-nor-steroid-3-carboxylsyrederivater | |
| NO178619C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive di-t-butylfenoler | |
| FI881223A0 (fi) | Menetelmä terapeuttisesti aktiivisten substituoitujen 9-aminotetrahydroakriinien ja niille läheisten yhdisteiden valmistamiseksi | |
| GR3001523T3 (en) | Substituted pyrimidine amides of oleic or linoleic acid as inhibitors of acyl-coa cholesterol acyltransferase | |
| NO176713C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-aminopyridinderivater | |
| FI96601C (fi) | Menetelmä terapeuttisesti aktiivisten tetratsolijohdannaisten valmistamiseksi | |
| FI883997A (fi) | Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 2-fenyyli-4-kinoliinikarboksyylihappojen valmistamiseksi | |
| HUT48895A (en) | Process for producing esters of pharmacologically active karboxylic acids | |
| FR2580667B1 (fr) | Procede de preparation enzymatique de l-amino acides renfermant du soufre | |
| NO173330C (no) | Anologifremgangsm}te for fremstilling av terapeutisk aktive pyrrolidin-derivater | |
| FI94348C (fi) | Analogiamenetelmä terapeuttisesti käyttökelpoisten bis-aryylifosfaattiesterijohdannaisten valmistamiseksi | |
| IL84426A (en) | Process for the isolation of l-amino acids | |
| AU610558C (en) | Saturated fatty acid amides as inhibitors of acyl-coa: cholesterol acyltransferase | |
| NO165396C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridin-5-karboksylsyre-estere. | |
| NO302577B1 (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive dekapeptider | |
| NO943458L (no) | Fremgangsmåte for fremstilling av terapeutisk aktivt amphiregulin | |
| IS3415A7 (is) | Aðferð til framleiðslu á lyfjafræðilegum virkum karboxýlsýruefnum | |
| FI96602C (fi) | Menetelmä terapeuttisesti aktiivisten tetratsolijohdannaisten valmistamiseksi | |
| NO174346C (no) | Fremgangsmåte for fremstilling av 5-aroyl-1,2-dihydro-3H-pyrrolo-(1,2-a)-pyrrol-1-carboxylsyrer og alkylestere og salter derav |